Elena Flowers
Overview
Explore the profile of Elena Flowers including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
577
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stroebel B, Gadgil M, Lewis K, Longoria K, Zhang L, Flowers E
J Clin Endocrinol Metab
. 2025 Mar;
PMID: 40067970
Context: Type 2 diabetes (T2D) remains a significant public health program, and current approaches to risk reduction fail to adequately prevent T2D in all individuals. Objective: The purpose of this...
2.
Flentje A, Sunder G, Carrico A, Asam K, Neilands T, Lisha N, et al.
Health Psychol
. 2025 Feb;
44(3):291-296.
PMID: 39992775
Objective: Past correlational research has shown that minority stress has direct and indirect effects on the biology of sexual minority people. This pilot randomized controlled trial (RCT) examined the potential...
3.
Lewis K, Stroebel B, Kanaya A, Aouizerat B, Longoria K, Flowers E
Res Sq
. 2025 Feb;
PMID: 39989952
Background: Metabolic syndrome is a pressing public health issue and risk factor for the development of type 2 diabetes (T2D) and cardiovascular disease (CVD), yet clinical practice is lacking in...
4.
Flowers E, Stroebel B, Gong X, Lewis K, Aouizerat B, Gadgil M, et al.
Front Endocrinol (Lausanne)
. 2024 Dec;
15:1511917.
PMID: 39698030
[This corrects the article DOI: 10.3389/fendo.2024.1419812.].
5.
Stroebel B, Gadgil M, Lewis K, Longoria K, Zhang L, Flowers E
bioRxiv
. 2024 Dec;
PMID: 39677703
Objective: The purpose of this study was to apply clustering methods to identify and characterize prediabetes phenotypes and their relationships with treatment arm and type 2 diabetes (T2D) outcomes in...
6.
Lindquist K, Ryan M, Scheuner M, Tamraz B, Flowers E, Harris-Wai J, et al.
J Contin Educ Health Prof
. 2024 Nov;
PMID: 39591498
Introduction: Advances in genomics are transforming clinical practice, but there are too few genetics professionals to meet increasing demand. Moreover, many nongeneticist clinicians feel unprepared to incorporate genetics into practice....
7.
Flowers E, Stroebel B, Lewis K, Aouizerat B, Gadgil M, Kanaya A, et al.
Front Endocrinol (Lausanne)
. 2024 Oct;
15:1419812.
PMID: 39359416
Objective: Circulating microRNAs show cross-sectional associations with overweight and obesity. Few studies provided data to differentiate between a snapshot perspective on these associations versus how microRNAs characterize prodromal risk from...
8.
Flowers E, Stroebel B, Gong X, Lewis K, Aouizerat B, Gadgil M, et al.
bioRxiv
. 2024 Jun;
PMID: 38895330
Objective: Circulating microRNAs show cross-sectional associations with overweight and obesity. Few studies provided data to differentiate between a snapshot perspective on these associations versus how microRNAs characterize prodromal risk from...
9.
Lewis K, Stroebel B, Zhang L, Aouizerat B, Mattis A, Flowers E
Int J Mol Sci
. 2024 Jun;
25(11).
PMID: 38891870
The Diabetes Prevention Program (DPP) randomized controlled trial demonstrated that metformin treatment reduced progression to type 2 diabetes (T2D) by 31% compared to placebo in adults with prediabetes. Circulating micro-ribonucleic...
10.
Lewis K, Stroebel B, Zhang L, Aouizerat B, Mattis A, Flowers E
Res Sq
. 2024 Feb;
PMID: 38313262
The Diabetes Prevention Program (DPP) randomized controlled trial demonstrated that metformin treatment reduced progression to type 2 diabetes (T2D) by 31% compared to placebo in adults with prediabetes. Circulating micro-ribonucleic...